SIGLEC12 and neoplasm: Furthermore, we analysed the effect of SIGLEC12 expression on the cancer stage (Fig. 3G–H), and the results showed an increase in tumour progression for all stages except for KIRP individuals (p = 0.8), (Fig. 3H).